1369532-69-3

Basic information

• Product Name: (S)-2-phenyl-1-(thiazol-2-yl)ethanamine
• Synonyms: 8-bromo-1-((S)-2-methoxypropyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one;8-Bromo-1,3-dihydro-1-[(2S)-2-methoxypropyl]-2H-imidazo[4,5-c]quinolin-2-one;8-bromo-1-[(2S)-2-methoxypropyl]-3H-imidazo[4,5-c]quinolin-2-one;EOS-60327
• CAS NO: 1369532-69-3
• Molecular Formula: C14H14BrN3O2
• Molecular Weight: 336.2
• EINECS: -0
• Mol File: 1369532-69-3.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.507±0.06 g/cm3(Predicted)
• PKA: 11.40±0.20(Predicted)
• CAS DataBase Reference: (S)-2-phenyl-1-(thiazol-2-yl)ethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-phenyl-1-(thiazol-2-yl)ethanamine(1369532-69-3)
• EPA Substance Registry System: (S)-2-phenyl-1-(thiazol-2-yl)ethanamine(1369532-69-3)

Safety Data

• Hazardous Substances Data: 1369532-69-3(Hazardous Substances Data)

Usage

General Description

(S)-2-phenyl-1-(thiazol-2-yl)ethanamine, also known as 2-Phenylthiazole, is a chemical compound with the molecular formula C11H12N2S. It is a chiral amine that contains both a phenyl and thiazole group. (S)-2-phenyl-1-(thiazol-2-yl)ethanamine is commonly used in pharmaceutical research and drug development due to its potential biological activity. Additionally, it has been studied for its potential anti-inflammatory and analgesic properties. 2-Phenylthiazole may also have applications in the synthesis of organic compounds and materials due to its unique structural features.

Upstream product

• 122794-99-4 6-bromo-4-hydroxyquinoline-3-carboxylic acid ethyl ester 
• 101937-44-4 diethyl 2-((4-bromophenylamino)methylene)malonate 
• 206257-39-8 6-bromo-4-chloroquinoline-3-carboxylic acid ethyl ester 
• 1386874-30-1 6-bromo-4-[[(2S)-2-methoxypropyl]amino]quinoline-3-carboxylic acid 
• 1386874-27-6 ethyl 6-bromo-4-[[(2S)-2-methoxypropyl]amino]quinoline-3-carboxylic acid 

Downstream Products

• 1386874-06-1 LY3023414 

Relevant articles and documents

PI3 KINASE/mTOR DUAL INHIBITOR

The present invention provides an imidazo[4,5-c]quinolin-2-one compound, or a pharmaceutically acceptable salt thereof, that inhibits both PI3K and mTOR and, therefore, is useful in the treatment of cancer.